Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces that Veronique Laberge has resigned from her position as Chief Financial Officer and Corporate Secretary. Her resignation is effective January 31, 2026.The Company has appointed Mr. Ajay Mishra as Chief Financial Officer and Corporate Secretary, effective January 31, 2026. Mr. Mishra will assume responsibility fo ...

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and global commercial activities.2025 Operational HighlightsResearch & DevelopmentDemonstrated feasibility of the Ready-to-Fill Nozzle, (a component used in sterile, re ...

Core Points - NuGen Medical Devices has announced that its EziAutoJector® product line has received NHS Drug Tariff approval in the UK, allowing diabetes patients to access the device at no cost as part of NHS-funded care [1][2][6] - The approval aligns with NICE guidelines, promoting personalized patient choice in insulin delivery methods, and ensures pharmacists are reimbursed for dispensing the product [2][6] - EziAutoJector® Ltd has established distribution channels through a major pharmaceutical wholesaler, targeting both high-street pharmacies and online pharmacy services [3] - A direct-to-consumer e-commerce channel will enhance accessibility for patients facing prescribing restrictions [4] - Transitioning to EziAutoJector® allows patients to eliminate the use of over 1,000 single-use insulin needles annually, reducing biohazardous waste and supporting NHS environmental goals [5][6] Company Overview - NuGen Medical Devices specializes in needle-free drug delivery technology, with its flagship InsuJet™ system approved in 42 countries [6]